Skip to main content

Table 3 Overall antibiotic use

From: Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome

 

Days of therapy/100 neutropenic days

Period I

Period II

Therapeutical agents

Carbapenems

40.3

31.6

Vancomycin

26.7

12.1

Ceftazidime

0.1

0.3

Ceftriaxone

0.8

0.8

Piperacillin/tazobactam

0.2

1.1

Penicillin

3.1

3.8

Aminoglycosides

0.5

0.6

Prophylactic agents

Clindamycin

10.9

7.0

Ciprofloxacin

65.8

60.1

Cotrimoxazole *

3.1

5.6

Cefazolin

4.1

15.0

Total

 

155.6

138.0

  1. *dose > 960 mg BID